This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Chr. Hansen Holding 관리

관리 기준 확인 4/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Mauricio Graber

최고 경영자

€3.2m

총 보상

CEO 급여 비율	31.3%
CEO 임기	5yrs
CEO 소유권	0.02%
경영진 평균 재임 기간	5.7yrs
이사회 평균 재임 기간	4.1yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Mauricio Graber 의 보수는 Chr. Hansen Holding 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Feb 28 2023	n/a	n/a	€229m
Nov 30 2022	n/a	n/a	€228m
Aug 31 2022	€3m	€1m	€225m
May 31 2022	n/a	n/a	€230m
Feb 28 2022	n/a	n/a	€221m
Nov 30 2021	n/a	n/a	€209m
Aug 31 2021	€3m	€986k	€199m
May 31 2021	n/a	n/a	€199m
Feb 28 2021	n/a	n/a	€213m
Nov 30 2020	n/a	n/a	€222m
Aug 31 2020	€3m	€969k	€232m
May 31 2020	n/a	n/a	€218m
Feb 29 2020	n/a	n/a	€221m
Nov 30 2019	n/a	n/a	€224m
Aug 31 2019	€3m	€953k	€229m
May 31 2019	n/a	n/a	€246m
Feb 28 2019	n/a	n/a	€240m
Nov 30 2018	n/a	n/a	€233m
Aug 31 2018	€2m	€238k	€228m

보상 대 시장: Mauricio 의 총 보상 ($USD 3.45M )은 MX 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 2.42M ).

보상과 수익: Mauricio 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Mauricio Graber (60 yo)

5yrs

테뉴어

€3,209,000

보상

Mr. Mauricio Graber has been Chief Executive Officer, President and Member of Executive Board of Chr. Hansen Holding A/S since joining it on June 1, 2018. Mr. Graber serves as Director of Jungbunzlauer Sui...

리더십 팀

이름	위치	테뉴어	보상	소유권
Mauricio Graber	CEO, President & Member of Executive Board	5yrs	€3.21m	0.024% € 39.0m
Lise Mortensen	Executive VP	2.7yrs	€1.32m	0.0021% € 3.5m
Thomas Schafer	Chief Science Advisor	1.3yrs	€1.58m	데이터 없음
Torsten Steenholt	Executive Vice President of Global Operations	6.4yrs	데이터 없음	데이터 없음
Henrik Nielsen	Executive VP & Chief Scientific Officer	1.2yrs	데이터 없음	데이터 없음
Anders Christensen	Vice President Group Strategy & Investor Relations	no data	데이터 없음	데이터 없음
Winnie Bugel	Executive Vice President of Compliance & Corporate Affairs	7yrs	데이터 없음	데이터 없음
Sanne Seyer-Hansen	Head of Media Relations	no data	데이터 없음	데이터 없음
Alice Larsen	Executive Vice President of Human Resources	6.9yrs	데이터 없음	데이터 없음
Laurent Hubert	VP & Head of Food	no data	데이터 없음	데이터 없음
Jacob Paulsen	Executive Vice President of Food Cultures & Enzymes	6.8yrs	데이터 없음	데이터 없음
Christian Barker	Executive Vice President of Health & Nutrition	no data	데이터 없음	데이터 없음

5.7yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 관리: CHR N 의 관리팀은 노련하고 경험 (평균 재직 기간 5.7 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Jesper Brandgaard	Independent Vice Chairman	5.6yrs	€154.00k	0.0035% € 5.8m
Dominique J. Reiniche	Independent Chairman of the Board	9.6yrs	€266.00k	0.0019% € 3.1m
Luis Rocamora	Independent Director	6.6yrs	€116.00k	0.0017% € 2.8m
Kasim Kutay	Representative Non Independent Director	less than a year	데이터 없음	데이터 없음
Heidi Kleinbach-Sauter	Independent Director	5.6yrs	€107.00k	0.00065% € 1.1m
Heine Dalsgaard	Representative Non Independent Director	less than a year	데이터 없음	데이터 없음
Charlotte Hemmingsen	Employee Representative Director	5.6yrs	€59.00k	0.00086% € 1.4m
Kim Soerensen	Employee Representative Director	5.6yrs	€59.00k	0.000080% € 132.5k
Kevin Lane	Independent Director	2.6yrs	€109.00k	0.00076% € 1.3m
Lise Kaae	Independent Director	2.6yrs	€105.00k	0.0010% € 1.7m
Casper Giedo	Employee Representative Director	1.6yrs	€45.00k	0.000020% € 33.1k
Karen Lauesen	Employee Representative Director	1.6yrs	€45.00k	0.000040% € 66.2k

4.1yrs

평균 재임 기간

58.5yo

평균 연령

경험이 풍부한 이사회: CHR N 의 이사회는 경험(평균 재직 기간 4.1 년)으로 간주됩니다.

This company is no longer active

Chr. Hansen Holding 관리

관리 기준 확인 4/4

주요 정보

최근 관리 업데이트

Novozymes A/S and Chr. Hansen Announce Executive Leadership Team and Organizational Structure

Executive VP recently bought Mex$1.5m worth of stock

Key Executive recently bought Mex$135k worth of stock

High number of new directors

High number of new directors

High number of new directors

Recent updates

Chr. Hansen Holding A/S(CPSE:CHR) dropped from FTSE All-World Index (USD)

Chr. Hansen Holding A/S(CPSE:CHR) dropped from OMX Copenhagen 20 Index

Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S (CPSE:CHR).

Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S (CPSE:CHR).

Chr. Hansen Holding A/S to Report Fiscal Year 2024 Results on Feb 06, 2025

Chr. Hansen Holding A/S Revises Revenue Guidance for January 1, 2023 – December 31, 2023

Novozymes A/S and Chr. Hansen Announce Executive Leadership Team and Organizational Structure

Chr. Hansen Holding A/S Provides Earnings Guidance for the Period September 1, 2022 – August 31, 2023

Executive VP recently bought Mex$1.5m worth of stock

First quarter 2023 earnings released: EPS: €0.38 (vs €0.35 in 1Q 2022)

Chr. Hansen Holding A/S Provides Revenue Guidance for 2022/23

Novozymes A/S (CPSE:NZYM B) agreed to acquire Chr. Hansen Holding A/S (CPSE:CHR).

Novozymes A/S (CPSE:NZYM B) agreed to acquire Chr. Hansen Holding A/S (CPSE:CHR).

Key Executive recently bought Mex$135k worth of stock

Chr. Hansen Holding A/S Approves Ordinary Dividend

Upcoming dividend of kr.7.04 per share

High number of new directors

Chr. Hansen Holding A/S to Report Q1, 2023 Results on Dec 12, 2022

Full year 2022 earnings released: EPS: €1.71 (vs €1.51 in FY 2021)

Chr. Hansen Holding A/S Proposes Ordinary Dividend for 2021/22

High number of new directors

Chr. Hansen Holding A/S to Report Q2, 2023 Results on Apr 13, 2023

Third quarter 2022 earnings released: EPS: €0.45 (vs €0.38 in 3Q 2021)

Chr. Hansen Holding A/S Provides Earnings Guidance for the Full Year of Fiscal 2022

High number of new directors

CEO 보상 분석

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령